William Schaffner, MD, medical director at the National Foundation for Infectious Diseases (NFID), and Patsy Stinchfield, RN, MS, CPNP, president-elect of NFID, discuss health care disparities related to respiratory syncytial virus (RSV), as well as solutions to close these gaps.
William Schaffner, MD, medical director at the National Foundation for Infectious Diseases (NFID), and Patsy Stinchfield, RN, MS, CPNP, president-elect of NFID, discuss health care disparities related to respiratory syncytial virus (RSV), as well as solutions to close these gaps.
Transcript
Besides overall lack of attention on RSV, what are some other RSV-related disparities?
Stinchfield: I think RSV disparities are similar to our other health care disparities in general and also specific to COVID-19. When we [tell] people, “You've got RSV, you should separate yourself from the other people in your family, go to another part of your house,” or with COVID-19, “You should be in your other room.” Well, a lot of families only have 1 room, so they may not be able to separate themselves as we've asked them to do when they have a viral infection. They may not be able to stay home from work; they may work in a public-facing job; they may need to ride public transportation.
Viral illnesses that are respiratory transmitted like this can impact people differently depending on their socioeconomic status. We have social determinants of health that we're paying attention to in a number of ways and for a number of reasons. I think RSV is going to be the same, that we're really going to need to make sure that people can afford monoclonal antibodies, that it isn't having to have large co-pays, and therefore people who don't have jobs or can't afford co-pays would not be able to access these good preventive therapies or treatments as they come to us in the future. We've got to make sure that the landscape is even and fair and accessible for everybody.
Schaffner: New therapies and new vaccines can help lower the disparity gap, reduce the disparity gap, but they have to be implemented. Just as Patsy says, we have to make sure that they are available in every way—in terms of access, in terms of expense, in terms of education, knowledge, acceptability. All of those issues, which continue to bedevil us in many aspects of medical care, will be in play. But having new therapies and having new vaccines gives us the opportunity to make in-roads into those gaps and to reduce them. The pediatric vaccination program, generally, in this country doesn't get enough credit because, by vaccinating all children, diseases of all kinds have been reduced or eliminated in the entire population. Urban, rural, white, black, tall, short, it doesn't make any difference because we've been able to reach out to the entire population and show what can be done if we are determined to do it.
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Latest Advances and Updates of Treatment in the Real World at AUA
May 1st 2024The annual meeting of the American Urological Association (AUA) not only presents the newest therapies coming out but showcases the latest in how treatments are being used in the real world, said Stephen Freedland, MD, of Cedars Sinai.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Latest Advances and Updates of Treatment in the Real World at AUA
May 1st 2024The annual meeting of the American Urological Association (AUA) not only presents the newest therapies coming out but showcases the latest in how treatments are being used in the real world, said Stephen Freedland, MD, of Cedars Sinai.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
2 Commerce Drive
Cranbury, NJ 08512